TRENDMAKER INC. LTD.

2024 Q3 Form 10-Q Financial Statement

#000149315224030471 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $165.2K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $123.9K $165.2K
YoY Change -25.03% -19.28%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $123.9K $165.2K
Total Long-Term Assets $0.00 $0.00
Total Assets $123.9K $165.2K
YoY Change -25.03% -19.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $5.298K $5.298K
YoY Change 0.0% -10.36%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $220.1K $220.1K
YoY Change 0.0% -0.28%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $220.1K $220.1K
Total Long-Term Liabilities
Total Liabilities $220.1K $220.1K
YoY Change 0.0% -0.28%
SHAREHOLDERS EQUITY
Retained Earnings -$922.8K -$881.4K
YoY Change 4.69% 4.61%
Common Stock $1.354K $1.354K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$96.27K -$54.91K
YoY Change
Total Liabilities & Shareholders Equity $123.9K $165.2K
YoY Change -25.03% -19.28%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
usd
CY2023Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
us-gaap Gross Profit
GrossProfit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address Address Line2
EntityAddressAddressLine2
Seksyen 9
dei City Area Code
CityAreaCode
+603
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
TMIN
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 us-gaap Assets Current
AssetsCurrent
123868 usd
CY2024Q2 us-gaap Assets
Assets
123868 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5298 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
220140 usd
CY2024Q2 us-gaap Liabilities
Liabilities
220140 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1354 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
825166 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-922792 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-96272 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123868 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Central Index Key
EntityCentralIndexKey
0001613685
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2024Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
usd
us-gaap Professional Fees
ProfessionalFees
usd
us-gaap Professional Fees
ProfessionalFees
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-200624
dei Entity Registrant Name
EntityRegistrantName
TRENDMAKER, INC. LIMITED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0979537
dei Entity Address Address Line1
EntityAddressAddressLine1
Lot 56935 Jalan 9/8
dei Entity Address City Or Town
EntityAddressCityOrTown
Bandar Baru Bangi
dei Entity Address Country
EntityAddressCountry
MY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43650
dei Local Phone Number
LocalPhoneNumber
8923 1880
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
true
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13537000 shares
CY2023Q4 us-gaap Assets Current
AssetsCurrent
147322 usd
CY2023Q4 us-gaap Assets
Assets
147322 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10894 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
225736 usd
CY2023Q4 us-gaap Liabilities
Liabilities
225736 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13537000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13537000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13537000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13537000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1354 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
825166 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-904934 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-78414 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147322 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8202 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6150 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17858 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14787 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8202 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6150 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17858 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14787 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-8202 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6150 usd
us-gaap Net Income Loss
NetIncomeLoss
-17858 usd
us-gaap Net Income Loss
NetIncomeLoss
-14787 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0006
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0006
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0005
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0005
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13537000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13537000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13537000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13537000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13537000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13537000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13537000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13537000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-78414 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-9656 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-88070 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-8202 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-96272 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-40127 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8637 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-48764 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-48764 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6150 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-54914 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-54914 usd
us-gaap Net Income Loss
NetIncomeLoss
-17858 usd
us-gaap Net Income Loss
NetIncomeLoss
-14787 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-23454 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-19787 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5596 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5000 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-08-21
CY2016Q1 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
5000000 shares
CY2016Q1 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.765 pure
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zwyiLp2J1sgf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zsVa1Bd9yPW6">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Significant estimates include valuation of in kind contribution of services, valuation of deferred tax assets. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13537000 shares
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 TMIN Accrued Expenses Current
AccruedExpensesCurrent
5298 usd
CY2023Q4 TMIN Accrued Expenses Current
AccruedExpensesCurrent
10894 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5298 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10894 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-922792 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-96272 usd
us-gaap Net Income Loss
NetIncomeLoss
-17858 usd

Files In Submission

Name View Source Status
0001493152-24-030471-index-headers.html Edgar Link pending
0001493152-24-030471-index.html Edgar Link pending
0001493152-24-030471.txt Edgar Link pending
0001493152-24-030471-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmin-20240630.xsd Edgar Link pending
tmin-20240630_cal.xml Edgar Link unprocessable
tmin-20240630_def.xml Edgar Link unprocessable
tmin-20240630_lab.xml Edgar Link unprocessable
tmin-20240630_pre.xml Edgar Link unprocessable